INTERNATIONAL PATENT: IMMUNEONCO BIOPHARMACEUTICALS (SHANGHAI) INC., 宜明昂科生物医药技术(上海)股份有限公司 FILES APPLICATION FOR "RECOMBINANT FUSION PROTEIN TARGETING VEGF AND EGFR AND PREPARATION AND USE THEREOF"

GENEVA, Dec. 21 -- IMMUNEONCO BIOPHARMACEUTICALS (SHANGHAI) INC. (Building 15, Lane 1000, Zhangheng RoadPudong New Area, Shanghai 201203), 宜明昂科生物医药技术(上海)股份有限公司 (中国上海市浦东新区张衡路1000弄15号) filed a patent application (PCT/CN2025/100830) for "RECOMBINANT FUSION PROTEIN TARGETING VEGF AND EGFR, AND PREPARATION AND USE THEREOF" on Jun 13, 2025. With publication no. WO/2025/256618, the details related to the patent application was published on Dec 18, 2025.

Notably, the patent application was submitted under the International Pate...